Identifying critical sites of PrP^c-PrP^Sc interaction in prion-infected cells by dominant-negative inhibition

References

• Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079 - 82; http://dx.doi.org/10.1126/science.274.5295.2079; PMID: 8953038
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 6; http://dx.doi.org/10.1126/science.1138718; PMID: 17991853
   PubMed Web of Science ®Google Scholar
• Taguchi Y, Mistica AMA, Kitamoto T, Schätzl HM. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein. PLoS Pathog 2013; 9:e1003466; http://dx.doi.org/10.1371/journal.ppat.1003466; PMID: 23825952
   PubMedGoogle Scholar
• Lawson VA, Priola SA, Wehrly K, Chesebro B. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J Biol Chem 2001; 276:35265 - 71; http://dx.doi.org/10.1074/jbc.M103799200; PMID: 11466311
   PubMed Web of Science ®Google Scholar
• Lawson VA, Priola SA, Meade-White K, Lawson M, Chesebro B. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. J Biol Chem 2004; 279:13689 - 95; http://dx.doi.org/10.1074/jbc.M303697200; PMID: 14736880
   PubMed Web of Science ®Google Scholar
• Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE, Prusiner SB. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A 1997; 94:10069 - 74; http://dx.doi.org/10.1073/pnas.94.19.10069; PMID: 9294164
   PubMed Web of Science ®Google Scholar
• Lee CI, Yang Q, Perrier V, Baskakov IV. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci 2007; 16:2166 - 73; http://dx.doi.org/10.1110/ps.072954607; PMID: 17766375
   PubMed Web of Science ®Google Scholar
• Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5:e1000535; http://dx.doi.org/10.1371/journal.ppat.1000535; PMID: 19649330
   PubMed Web of Science ®Google Scholar
• Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, Prusiner SB. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 2000; 74:4351 - 60; http://dx.doi.org/10.1128/JVI.74.9.4351-4360.2000; PMID: 10756050
   PubMed Web of Science ®Google Scholar
• Geissen M, Mella H, Saalmüller A, Eiden M, Proft J, Pfaff E, Schätzl HM, Groschup MH. Inhibition of prion amplification by expression of dominant inhibitory mutants--a systematic insertion mutagenesis study. Infect Disord Drug Targets 2009; 9:40 - 7; http://dx.doi.org/10.2174/1871526510909010040; PMID: 19200014
   PubMedGoogle Scholar
• Singh J, Udgaonkar JB. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry. J Mol Biol 2013; 425:3510 - 21; http://dx.doi.org/10.1016/j.jmb.2013.06.009; PMID: 23811055
   PubMed Web of Science ®Google Scholar
• Smirnovas V, Kim J-I, Lu X, Atarashi R, Caughey B, Surewicz WK. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. J Biol Chem 2009; 284:24233 - 41; http://dx.doi.org/10.1074/jbc.M109.036558; PMID: 19596861
   PubMed Web of Science ®Google Scholar
• Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, Surewicz WK. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol 2011; 18:504 - 6; http://dx.doi.org/10.1038/nsmb.2035; PMID: 21441913
   PubMed Web of Science ®Google Scholar
• Bocharova OV, Breydo L, Salnikov VV, Gill AC, Baskakov IV. Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci 2005; 14:1222 - 32; http://dx.doi.org/10.1110/ps.041186605; PMID: 15802644
   PubMed Web of Science ®Google Scholar
• Zou W-Q, Capellari S, Parchi P, Sy M-S, Gambetti P, Chen SG. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 2003; 278:40429 - 36; http://dx.doi.org/10.1074/jbc.M308550200; PMID: 12917418
   PubMed Web of Science ®Google Scholar
• Kyle LM, John TR, Schätzl HM, Lewis RV. Introducing a rigid loop structure from deer into mouse prion protein increases its propensity for misfolding in vitro. PLoS One 2013; 8:e66715; http://dx.doi.org/10.1371/journal.pone.0066715; PMID: 23825561
   PubMedGoogle Scholar
• Dutta A, Chen S, Surewicz WK. The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein. FEBS Lett 2013; 587:2918 - 23; http://dx.doi.org/10.1016/j.febslet.2013.07.023; PMID: 23892077
   PubMed Web of Science ®Google Scholar
• Chatterjee B, Lee C-Y, Lin C, Chen EH-L, Huang C-L, Yang C-C, Chen RP-Y. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126. PLoS One 2013; 8:e67967; http://dx.doi.org/10.1371/journal.pone.0067967; PMID: 23844138
   PubMedGoogle Scholar
• Surewicz WK, Jones EM, Apetri AC. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro. Acc Chem Res 2006; 39:654 - 62; http://dx.doi.org/10.1021/ar050226c; PMID: 16981682
   PubMed Web of Science ®Google Scholar
• Moore RA, Herzog C, Errett J, Kocisko DA, Arnold KM, Hayes SF, Priola SA. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation. Protein Sci 2006; 15:609 - 19; http://dx.doi.org/10.1110/ps.051822606; PMID: 16452616
   PubMed Web of Science ®Google Scholar
• Singh J, Sabareesan AT, Mathew MK, Udgaonkar JB. Development of the structural core and of conformational heterogeneity during the conversion of oligomers of the mouse prion protein to worm-like amyloid fibrils. J Mol Biol 2012; 423:217 - 31; http://dx.doi.org/10.1016/j.jmb.2012.06.040; PMID: 22789566
   PubMed Web of Science ®Google Scholar
• Pirisinu L, Nonno R, Esposito E, Benestad SL, Gambetti P, Agrimi U, Zou W-Q. Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy. PLoS One 2013; 8:e66405; http://dx.doi.org/10.1371/journal.pone.0066405; PMID: 23826096
   PubMedGoogle Scholar
• Taguchi Y, Mohri S, Ironside JW, Muramoto T, Kitamoto T. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am J Pathol 2003; 163:2585 - 93; http://dx.doi.org/10.1016/S0002-9440(10)63613-9; PMID: 14633630
   PubMed Web of Science ®Google Scholar
• Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, Parchi P, Gambetti P, Will R, Ironside J, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A 2003; 100:4784 - 9; http://dx.doi.org/10.1073/pnas.2627989100; PMID: 12684540
   PubMed Web of Science ®Google Scholar
• Tamgüney G, Giles K, Oehler A, Johnson NL, DeArmond SJ, Prusiner SB. Chimeric elk/mouse prion proteins in transgenic mice. J Gen Virol 2013; 94:443 - 52; http://dx.doi.org/10.1099/vir.0.045989-0; PMID: 23100369
   PubMed Web of Science ®Google Scholar